• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部皮肤黑色素瘤。512例患者的预后因素及无复发生存率

Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.

作者信息

Andersson A P, Gottlieb J, Drzewiecki K T, Hou-Jensen K, Sondergaard K

机构信息

Department of Reconstructive Surgery, University State Hospital, Copenhagen, Denmark.

出版信息

Cancer. 1992 Mar 1;69(5):1153-6. doi: 10.1002/cncr.2820690515.

DOI:10.1002/cncr.2820690515
PMID:1739914
Abstract

The clinicopathologic and therapeutic data of 512 patients, with clinical Stage I invasive head and neck melanoma of the skin were retrospectively evaluated. There were 287 females and 225 males. Median age at primary surgery was 65 years (range, 18 to 96 years). Median observation period was 5 years (range, 1 month to 25 years). Site of first recurrence was local in 7% (38 of 512), regional in 13% (67 of 512) and distant in 6% (31 of 512). Sex, age, ulcerated tumor, and tumor thickness were found to act as independent risk factors to recurrence-free survival by Cox multivariate regression analysis. In addition, size of excision margin was found to be of no significance to survival without relapse when adjusting for the independent risk factors.

摘要

对512例临床I期皮肤侵袭性头颈部黑色素瘤患者的临床病理及治疗数据进行了回顾性评估。其中女性287例,男性225例。初次手术时的中位年龄为65岁(范围18至96岁)。中位观察期为5年(范围1个月至25年)。首次复发部位为局部的占7%(512例中的38例),区域的占13%(512例中的67例),远处的占6%(512例中的31例)。通过Cox多因素回归分析发现,性别、年龄、溃疡型肿瘤及肿瘤厚度是无复发生存的独立危险因素。此外,在调整独立危险因素后,切缘大小对无复发生存无显著影响。

相似文献

1
Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.头颈部皮肤黑色素瘤。512例患者的预后因素及无复发生存率
Cancer. 1992 Mar 1;69(5):1153-6. doi: 10.1002/cncr.2820690515.
2
[Significant prognostic factors for recurrence-free survival after surgical treatment of head-neck melanoma].[头颈部黑色素瘤手术治疗后无复发生存的显著预后因素]
Ugeskr Laeger. 1993 Aug 2;155(31):2397-9.
3
Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.儿童头颈部黑色素瘤的生存和手术结果。
JAMA Otolaryngol Head Neck Surg. 2017 Jan 1;143(1):34-40. doi: 10.1001/jamaoto.2016.2630.
4
Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.薄型头颈部皮肤黑色素瘤治疗策略的演变:1 家机构的经验。
Head Neck. 2011 Jan;33(1):7-12. doi: 10.1002/hed.21403.
5
Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.前哨淋巴结活检阴性后头颈部皮肤黑色素瘤复发
Head Neck. 2015 Aug;37(8):1116-21. doi: 10.1002/hed.23718. Epub 2014 Jul 11.
6
Scalp melanoma and in-transit metastases: a retrospective case-controlled study.头皮黑色素瘤及途中转移:一项回顾性病例对照研究。
Am Surg. 2014 Dec;80(12):1272-4.
7
Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.黑色素瘤中前哨淋巴结假阴性的预测因素及生存影响
Ann Surg Oncol. 2016 Mar;23(3):1012-8. doi: 10.1245/s10434-015-4912-6. Epub 2015 Nov 19.
8
A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.一项回顾性观察研究,比较仅接受切除术治疗的原发性皮肤恶性黑色素瘤患者与先行切除活检再行更广泛局部切除的患者。
Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x.
9
Cutaneous melanoma of the head and neck.头颈部皮肤黑色素瘤
Am J Surg. 1989 Oct;158(4):388-91. doi: 10.1016/0002-9610(89)90141-4.
10
Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.头颈部恶性黑色素瘤的选择性、治疗性及延迟性淋巴结清扫术:对1970年至1998年1444例患者的分析
Laryngoscope. 2002 Jan;112(1):99-110. doi: 10.1097/00005537-200201000-00018.

引用本文的文献

1
Enhancing Predictive Accuracy for Recurrence-Free Survival in Head and Neck Tumor: A Comparative Study of Weighted Fusion Radiomic Analysis.提高头颈部肿瘤无复发生存的预测准确性:加权融合放射组学分析的比较研究
Diagnostics (Basel). 2024 Sep 14;14(18):2038. doi: 10.3390/diagnostics14182038.
2
Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma.结膜和眼睑黑色素瘤检查点抑制剂治疗的临床进展
Int Ophthalmol Clin. 2020 Spring;60(2):77-89. doi: 10.1097/IIO.0000000000000308.
3
Melanoma of the head and neck.头颈部黑色素瘤
Curr Treat Options Oncol. 2005 Jan;6(1):19-30. doi: 10.1007/s11864-005-0010-5.